CX-5461 induces autophagy and inhibits tumor growth via mammalian target of rapamycin-related signaling pathways in osteosarcoma

Overview of attention for article published in OncoTargets and therapy, September 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

patent: 4 patents

facebook: 1 Facebook page

Citations

dimensions_citation: 44 Dimensions

Readers on

mendeley: 45 Mendeley

Summary Patents Facebook Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

Quinolone analogs and their salts, compositions, and method for their use

Grant US-11524012-B1

United States of America

Combination therapy of tetracyclic quinolone analogs for treating cancer

Grant US-11229654-B2

United States of America

Combination therapy of tetracyclic quinolone analogs for treating cancer

Grant US-10857156-B2

United States of America

COMBINATION THERAPY OF TETRACYCLIC QUINOLONE ANALOGS FOR TREATING CANCER

Application EP-3377068-A4

European Patent Office